These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis, antimicrobial activity and QSAR studies of 2,5-disubstituted benzoxazoles. Arisoy M; Temiz-Arpaci O; Yildiz I; Kaynak-Onurdag F; Aki E; Yalcin I; Abbasoglu U SAR QSAR Environ Res; 2008; 19(5-6):589-612. PubMed ID: 18853304 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles. Yildiz-Oren I; Tekiner-Gulbas B; Yalcin I; Temiz-Arpaci O; Aki-Sener E; Altanlar N Arch Pharm (Weinheim); 2004 Jul; 337(7):402-10. PubMed ID: 15237391 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimicrobial activity of some 5-[2-(morpholin-4-yl)acetamido] and/or 5-[2-(4-substituted piperazin-1-yl)acetamido]-2-(p-substituted phenyl)benzoxazoles. Temiz-Arpaci O; Ozdemir A; Yalçin I; Yildiz I; Aki-Sener E; Altanlar N Arch Pharm (Weinheim); 2005 Mar; 338(2-3):105-11. PubMed ID: 15765492 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of some diguanidino 1-methyl-2,5-diaryl-1H-pyrroles as antifungal agents. Jana GH; Jain S; Arora SK; Sinha N Bioorg Med Chem Lett; 2005 Aug; 15(15):3592-5. PubMed ID: 15978808 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of some new benzoxazoles. Temiz-Arpaci O; Yildiz I; Ozkan S; Kaynak F; Aki-Sener E; Yalçin I Eur J Med Chem; 2008 Jul; 43(7):1423-31. PubMed ID: 18023934 [TBL] [Abstract][Full Text] [Related]
9. Fluconazole analogues containing 2H-1,4-benzothiazin-3(4H)-one or 2H-1,4-benzoxazin-3(4H)-one moieties, a novel class of anti-Candida agents. Borate HB; Maujan SR; Sawargave SP; Chandavarkar MA; Vaiude SR; Joshi VA; Wakharkar RD; Iyer R; Kelkar RG; Chavan SP; Kunte SS Bioorg Med Chem Lett; 2010 Jan; 20(2):722-5. PubMed ID: 19963383 [TBL] [Abstract][Full Text] [Related]
10. QSARs of some novel isosteric heterocyclics with antifungal activity. Yalçin I; Oren I; Temiz O; Sener EA Acta Biochim Pol; 2000; 47(2):481-6. PubMed ID: 11051213 [TBL] [Abstract][Full Text] [Related]
11. Phenotypic characterization and in vitro antifungal sensitivity of Candida spp. and Malassezia pachydermatis strains from dogs. Brito EH; Fontenelle RO; Brilhante RS; Cordeiro RA; Soares Júnior FA; Monteiro AJ; Sidrim JJ; Rocha MF Vet J; 2007 Jul; 174(1):147-53. PubMed ID: 17188535 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of new linear guanidines and macrocyclic amidinourea derivatives endowed with high antifungal activity against Candida spp. and Aspergillus spp. Manetti F; Castagnolo D; Raffi F; Zizzari AT; Rajamäki S; D'Arezzo S; Visca P; Cona A; Fracasso ME; Doria D; Posteraro B; Sanguinetti M; Fadda G; Botta M J Med Chem; 2009 Dec; 52(23):7376-9. PubMed ID: 19650630 [TBL] [Abstract][Full Text] [Related]
13. Evolution of ergosterol biosynthesis inhibitors as fungicidal against Candida. Ahmad A; Khan A; Manzoor N; Khan LA Microb Pathog; 2010 Jan; 48(1):35-41. PubMed ID: 19835945 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel pyrazino[2,1-a]isoquinolin derivatives with potent antifungal activity. Tang H; Zheng CH; Zhu J; Fu BY; Zhou YJ; Lv JG Arch Pharm (Weinheim); 2010 Jun; 343(6):360-6. PubMed ID: 20232375 [TBL] [Abstract][Full Text] [Related]
15. Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies. Di Santo R; Tafi A; Costi R; Botta M; Artico M; Corelli F; Forte M; Caporuscio F; Angiolella L; Palamara AT J Med Chem; 2005 Aug; 48(16):5140-53. PubMed ID: 16078834 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antifungal activity of isosteric analogues of benzoheterocyclic N-myristoyltransferase inhibitors. Sheng C; Xu H; Wang W; Cao Y; Dong G; Wang S; Che X; Ji H; Miao Z; Yao J; Zhang W Eur J Med Chem; 2010 Sep; 45(9):3531-40. PubMed ID: 20615585 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles. Tekiner-Gulbas B; Temiz-Arpaci O; Yildiz I; Altanlar N Eur J Med Chem; 2007 Oct; 42(10):1293-9. PubMed ID: 17337097 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of inexpensive topical alternatives against Candida spp. isolated from the oral cavity of HIV-infected patients. Traboulsi RS; Mukherjee PK; Ghannoum MA Int J Antimicrob Agents; 2008 Mar; 31(3):272-6. PubMed ID: 18242063 [TBL] [Abstract][Full Text] [Related]
19. In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology. Szabó Z; Szilágyi J; Tavanti A; Kardos G; Rozgonyi F; Bayegan S; Majoros L Diagn Microbiol Infect Dis; 2009 Jul; 64(3):283-8. PubMed ID: 19394787 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of phenyl-O,N,N-azoxycyanide towards Candida spp. and Torulopsis spp. Tullio V; Bianco MA Boll Chim Farm; 1991 May; 130(5):166-8. PubMed ID: 1760149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]